INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 6 filers reported holding INTEC PHARMA LTD JERUSALEM in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -98.7% | 17,734 | -98.4% | 0.00% | – |
| Q2 2020 | $313,000 | +469.1% | 1,104,589 | +297.5% | 0.00% | – |
| Q1 2020 | $55,000 | -90.7% | 277,903 | +103.4% | 0.00% | -100.0% |
| Q2 2019 | $593,000 | +143.0% | 136,601 | +216.9% | 0.00% | – |
| Q3 2018 | $244,000 | -49.9% | 43,100 | -58.6% | 0.00% | – |
| Q2 2018 | $487,000 | +407.3% | 104,112 | +584.3% | 0.00% | – |
| Q1 2018 | $96,000 | -86.0% | 15,214 | -88.6% | 0.00% | -100.0% |
| Q4 2017 | $688,000 | -4.4% | 133,500 | +66.0% | 0.00% | 0.0% |
| Q3 2017 | $720,000 | +367.5% | 80,400 | +197.8% | 0.00% | – |
| Q2 2017 | $154,000 | +133.3% | 27,000 | +108.6% | 0.00% | – |
| Q1 2017 | $66,000 | +3.1% | 12,944 | +15.6% | 0.00% | – |
| Q4 2016 | $64,000 | -58.4% | 11,200 | -57.3% | 0.00% | – |
| Q3 2016 | $154,000 | – | 26,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Taylor Frigon Capital Management LLC | 414,471 | $302,000 | 0.22% |
| MEITAV INVESTMENT HOUSE LTD | 2,424,516 | $1,694,000 | 0.12% |
| Harel Insurance Investments & Financial Services Ltd. | 530,573 | $387,000 | 0.02% |
| Virtu Financial LLC | 131,642 | $96,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 65,649 | $48,000 | 0.00% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,460,000 | $1,064,000 | 0.00% |
| ARK Investment Management | 144,414 | $105,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 61,558 | $46,000 | 0.00% |
| A.R.T. Advisors, LLC | 47,576 | $35,000 | 0.00% |
| HRT FINANCIAL LP | 29,807 | $21,000 | 0.00% |